Fergal Hill

Title: Fergal Hill: Innovator in Influenza Vaccine Development

Introduction

Fergal Hill is a notable inventor based in Lyons, France, recognized for his contributions to the field of immunology and vaccine development. With a total of six patents to his name, Hill has made significant strides in creating innovative solutions for influenza prevention and treatment.

Latest Patents

One of Hill's latest patents focuses on influenza nucleoprotein vaccines. This invention involves a fusion protein that comprises a variant of a nucleoprotein antigen from Influenza strains A, B, or C, along with a variant of a C4bp oligomerization domain. This combination aims to enhance the cellular immunogenicity of the nucleoprotein antigen, providing a promising avenue for vaccine development against influenza disease. Another significant patent involves modified coiled coil type proteins with improved properties. This application describes a modified protein that includes a coiled coil domain linked to a specific peptide sequence. The modified protein exhibits increased affinity for negatively charged polymers, such as nucleic acids or heparin, and demonstrates enhanced immunogenicity, making it a valuable asset in vaccine formulation.

Career Highlights

Throughout his career, Fergal Hill has worked with several prominent companies, including Imaxio and Isis Innovation Limited. His experience in these organizations has allowed him to refine his expertise in vaccine technology and immunotherapy.

Collaborations

Hill has collaborated with notable colleagues, including Judith Del Campo Ascarateil and Jean-Baptiste Marchand. These partnerships have contributed to the advancement of his research and the successful development of his patented innovations.

Conclusion

Fergal Hill's work in the field of influenza vaccine development showcases his commitment to advancing medical science through innovative inventions. His patents reflect a deep understanding of immunology and a dedication to improving public health.